HeartSciences Inc.

HeartSciences Inc. (HSCS) priced its initial public offering on Jun 17, 2022 at $4.25 per share, below its $4.50–$5.50 range, raising $6.4M, and listed on Nasdaq. At the IPO price its market capitalization was about $34.2M. Benchmark was lead-left underwriter. Jackson Walker advised the company and Mitchell Silberberg & Knupp advised the underwriters.

HeartSciences Inc. is a medical technology company applying AI to the electrocardiogram (ECG) to expand its clinical usefulness as a cardiac screening tool. Its first product candidate for FDA clearance is the MyoVista wavECG, a resting 12-lead ECG.

Status

IPO

Ticker

HSCS

Exchange

Nasdaq

Priced

Jun 17, 2022

IPO price

$4.25

Price range

$4.50–$5.50

Raised

$6.4M

Market cap at IPO price

$34.2M

First filed

May 17, 2022

Underwriters

Benchmark

Company counsel

Jackson Walker

Underwriters' counsel

Mitchell Silberberg & Knupp

Sector

Financials

Country / state

TX

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.